Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07124130 · ClinicalTrials.gov registry record · Phase 4
Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor
A Phase 4 study of Induced Labor, sponsored by Eastern Virginia Medical School.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 158
- Enrollment target
- 2
- Study locations
NCT07124130: Recruiting Phase 4 study of Induced Labor, sponsored by Eastern Virginia Medical School.
NCT07124130 is a Phase 4 study of Induced Labor that is actively recruiting participants, run by Eastern Virginia Medical School. The registered enrollment target is 158 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07124130, a Phase 4 study of Induced Labor, is actively recruiting participants, sponsored by Eastern Virginia Medical School.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 158 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to determine which of two types of standard intravenous (IV) fluids (a combination of 5% dextrose and Lactated Ringers solution and Lactated Ringers solution alone) has a better influence on labor when inducing labor in pregnant women. The main questions it aims to answer are: 1. Does the use of 5% dextrose and Lactated Ringers lead to a shorter labor than the use of just Lactated Ringers? 2. Does the use of 5% dextrose and Lactated Ringers increase the risk of neonatal hypoglycemia when compared to Lactated Ringers? Participants in this trial will be randomly assigned to one of two groups: a group that receives a solution of 5% dextrose and Lactated Ringers, and a group that receives Lactated Ringers alone. Researchers will compare the outcomes of the two groups to see which IV fluid is more effective.
Conditions Studied
Interventions
- DRUG 5% Dextrose (D5) in Normal Saline (NS)
- DRUG Lactate Ringer
Study Locations (2)
Virginia
- Sentara Norfolk General Hospital - Norfolk
Other
- Policlinico di Modena - Modena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
What NCT07124130 shows while recruiting
NCT07124130 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Induced Labor appearing as the primary indexed condition, and to 2 interventions - of which 5% Dextrose (D5) in Normal Saline (NS) is the first listed.
NCT07124130 reports a single indexed study location in Virginia, Other.
Frequently Asked Questions
What is clinical trial NCT07124130 about?
NCT07124130 is a clinical study titled "Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor". The goal of this clinical trial is to determine which of two types of standard intravenous (IV) fluids (a combination of 5% dextrose and Lactated Ringers solution and Lactated Ringers solution alone) has a better influence on labor when inducing labor in pregnant women. The main questions it aims to...
What is the current status of trial NCT07124130?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 158 participants. The study started on 2025-09. Estimated completion is 2026-03.
What conditions does trial NCT07124130 study?
This clinical trial studies the following conditions: Induced Labor.
What interventions are being tested in trial NCT07124130?
The interventions under investigation include: 5% Dextrose (D5) in Normal Saline (NS) (DRUG), Lactate Ringer (DRUG).
Who is sponsoring clinical trial NCT07124130?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07124130 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07124130's enrollment target sits among peer trials
158 516th of 2000 higher than 1,483 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia